Novel coronavirus: three cases reported in France
The first confirmed cases in Europe are not unexpected. The fact that these cases were identified, proves that detection and confirmation of this novel virus is working in France, showing a high level of preparedness to prevent and control possible infections of 2019-nCoV.
Are European laboratories ready to detect COVID-19?
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
ECDC statement on the rapid increase of COVID-19 cases in Italy
In the last 24 hours, the Italian Ministry of Health confirmed an increasing number of COVID-19 cases, including two deaths, clustered in two regions in Northern Italy as well as single cases in other regions in Northern Italy.
ECDC releases COVID-19 vaccination rollout strategies for EU/EEA
On 22 December ECDC released the technical report titled ‘COVID-19 vaccination and prioritisation strategies in the EU/EEA’, following the European Medicines Agency (EMA) recommendation for authorisation of the vaccine Comirnaty, developed by BioNTech and Pfizer.
Detailed data on COVID-19 vaccination progress in the EU/EEA available via Vaccine Tracker and in weekly reports
Vaccination campaigns against COVID-19 disease are well under way in all EU/EEA countries, and more detailed information is now available on the ECDC website.
SARS-CoV-2 variants of concern pose a higher risk for hospitalisation and intensive care admission
Since the discovery of SARS-CoV-2, three variants of concern (VOC), first identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1), have been associated with higher transmissibility and severity of disease, with potential implications for acquired immunity or the effectiveness of current vaccines.